Top

CardioVascular and Interventional Radiology

Published in:

01-08-2012 | Review

Venous Access Ports: Indications, Implantation Technique, Follow-Up, and Complications

Author: Eric M. Walser

Published in: CardioVascular and Interventional Radiology | Issue 4/2012

Abstract

The subcutaneous venous access device (SVAD or “port”) is a critical component in the care of patients with chronic disease. The modern SVAD provides reliable access for blood withdrawal and medication administration with minimal disruption to a patient’s lifestyle. Because of improved materials and catheter technology, today’s ports are lighter and stronger and capable of high-pressure injections of contrast for cross-sectional imaging. The majority of SVAD placement occurs in interventional radiology departments due to their ability to provide this service at lower costs, lower, complication rates, and greater volumes. Port-insertion techniques vary depending on the operator, but all consist of catheter placement in the central venous circulation followed by subcutaneous pocket creation and port attachment to the catheter with fixation and closure of the pocket. Venous access challenges occasionally occur in patients with central vein occlusions, necessitating catheterization of collateral veins or port placement in alternate locations. Complications of SVADs include those associated with the procedure as well as short- (<30 days) and long-term problems. Procedural and early complications are quite rare due to the near-universal use of real-time ultrasound guidance for vein puncture, but they can include hematoma, catheter malposition, arrhythmias, and pneumothorax. Late problems include both thrombotic complications (native venous or port-catheter thrombosis) and infections (tunnel or pocket infections or catheter-associated bloodstream infections). Most guidelines suggest that 0.3 infections/1000 catheter days is an appropriate upper threshold for the insertion of SVADs.

Forssmann W (1929) Die Sondierung rechten Herzens. Klin Wochenschr 8:2080

Aubaniac R (1952) Subclavian intravenous injection: advantages and technic. Presse Med 60(68):1456PubMed

Stevens B, Barton SE, Brechbill M et al. (2000) A randomized prospective trial of conventional vascular ports vs. the Vortex “clear flow” reservoir port. JVAD

Ryder MA (1995) Peripheral access options. Surg Oncol Clin North Am 4:395–427

Foley MJ (1995) Radiologic placement of long-term central venous peripheral access system ports (PAS port): results in 150 patients. J Vasc Interv Radiol 6(2):255–262PubMedCrossRef

Vardy J, Engelhardt K, Cox K et al (2004) Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. Br J Cancer 91(6):1045–1059PubMed

Teichgräber UK, Kausche S, Nagel SN et al (2011) Outcome analysis in 3, 160 implantations of radiologically guided placements of totally implantable central venous port systems. Eur Radiol 21(6):1224–1232PubMedCrossRef

Haindl H, Müller H (1988) An atraumatic needle for the puncture of ports and pumps. Klin Wochenschr 66(20):1006–1009PubMedCrossRef

Müller H, Zierski J (1988) The Huber needle as a special cannula for the puncture of implanted ports and pumps: a mistake in multiple variations. Klin Wochenschr 66(19):963–969PubMedCrossRef

10.

Biffi R, De Braud F, Orsi F et al (2001) A randomized prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92(5):1204–1212PubMedCrossRef

11.

Hsieh CC, Weng HH, Huang WS et al (2009) Analysis of risk factors for central venous port failure in cancer patients. World J Gastroenterol 15(37):4709–4714PubMedCrossRef

12.

Ong CK, Sudhakar KV, Lau GB et al (2010) Prospective randomized comparative evaluation of proximal valve polyurethane and distal valve silicone peripherally inserted central catheters. J Vasc Interv Radiol 21:1191–1196PubMedCrossRef

13.

Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81:1159–1171PubMedCrossRef

14.

Akahane A, Sone M, Ehara S et al. (2010) Subclavian vein versus arm vein for totally implantable central venous port for patients with head and neck cancer: a retrospective comparative analysis. Cardiovasc Intervent Radiol (in press)

15.

Ghandi RT, Getrajdman GI, Brown KT et al (2003) Placement of subcutaneous chest wall ports ipsilateral to axillary lymph node dissection. J Vasc Interv Radiol 14:1063–1065CrossRef

16.

Erinjeri JP, Fong AJ, Kemeny NE et al (2011) Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement. Cancer 117(6):1296–1301PubMedCrossRef

17.

Sansivero GE (2010) Features and selection of vascular access devices. Semin Oncol Nurs 26(2):88–101PubMedCrossRef

18.

Ryan JM, Ryan BM, Smith TP (2004) Antibiotic prophylaxis in interventional radiology. J Vasc Interv Radiol 15:547–556PubMedCrossRef

19.

Venkatesan AM, Kundu S, Sacks D (2010) Practice guideline for adult antibiotic prophylaxis during vascular and interventional radiology procedures. J Vasc Interv Radiol 21:1611–1630PubMedCrossRef

20.

Denys GB, Uretsky BF, Reddy PS (1993) Ultrasound-assisted cannulation of the internal jugular vein: a prospective comparison to the external landmark-guided technique. Circulation 87:1557–1562PubMedCrossRef

21.

Skolnick ML (1994) The role of sonography in the placement and management of jugular and subclavian central venous catheters. AJR Am J Roentgenol 163:291–295PubMed

22.

Contractor SG, Phatak TD, Klyde D et al (2009) Single-incision technique for tunneled venous access. J Vasc Interv Radiol 20(8):1052–1058PubMedCrossRef

23.

Cil BE, Canyigit M, Peynircioglu B et al (2006) Subcutaneous venous port implantation in adult patients: a single center experience. Diagn Interv Radiol 12:93–98PubMed

24.

McNulty NJ, Perrich KD, Silas AM et al (2010) Implantable subcutaneous venous access devices: is port fixation necessary? A review of 534 cases. Cardiovasc Intervent Radiol 33(4):751–755PubMedCrossRef

25.

Singer AJ, Thode HC Jr (2004) A review of the literature on octylcyanoacrylate tissue adhesive. Am J Surg 187(2):238–248PubMedCrossRef

26.

Merrer J, De Jonghe B, Golliot F et al (2001) Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 286(6):700–707PubMedCrossRef

27.

Hamilton HC, Foxcroft DR (2007) Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapy. Cochrane Database Syst Rev 3:CD004084

28.

Simpson KR, Hovsepian DM, Picus D (1998) Interventional radiologic placement of chest wall ports: Results and complications in 161 consecutive placements. J Vasc Interv Radiol 8:189–195CrossRef

29.

Ballarini C, Intra M, Ceretti AP et al (1999) Complications of subcutaneous infusion port in the general oncology population. Oncology 56:97–102PubMedCrossRef

30.

Dariushnia SR, Wallace MJ, Siddiqi NH et al (2010) Quality improvement guidelines for central venous access. J Vasc Interv Radiol 21:976–981PubMedCrossRef

31.

Lyon SM, Given M, Marshall NL (2008) Interventional radiology in the provision and maintenance of long-term central venous access. J Med Imaging Radiat Oncol 52:10–17PubMedCrossRef

32.

Bessoud B, de Baere T, Kuoch V et al (2003) Experience at a single institution with endovascular treatment of mechanical complications caused by implanted central venous access devices in pediatric and adult patients. AJR Am J Roentgenol 180:527–532PubMed

33.

Schwarz RD, Coit DG, Groeger JS (2000) Transcutaneously tunneled central venous lines in cancer patients: An analysis of device-related morbidity factors based on prospective data collection. Ann Surg Oncol 7:441–449PubMedCrossRef

34.

NKF-K/DOQI (2001) Clinical practice guidelines for vascular access: Update 2000. Am J Kidney Dis 37(Suppl):S137–S181

35.

Marcy PY (2008) Central venous access: techniques and indications in oncology. Eur Radiol 18:2333–2344PubMedCrossRef

36.

Yildizeli B, Lacin T, Batirel HF et al (2004) Complications and management of long-term central venous access catheters and ports. J Vasc Access 5(4):174–178PubMed

37.

Douard MC, Arlet G, Longuet P et al (1999) Diagnosis of venous access port-related infections. Clin Infect Dis 29(5):1197–1202PubMedCrossRef

38.

Capdevila J, Planes AM, Palomar M et al (1992) Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis 11(5):403–407PubMedCrossRef

39.

Bouza E, Burillo A, Munoz P (2002) Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 8(5):265–274PubMedCrossRef

40.

Biffi R, de Braud F, Orsi F et al (1998) Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9:767–773PubMedCrossRef

41.

O’Grady NP, Alexander M, Dellinger EP et al (2002) Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 30:476–489PubMedCrossRef

42.

Faetkenhuer G, Buchheidt D, Cornely OA et al (2003) Central venous catheter (CVC)-related infections in neutropenic patients. Ann Hematol 82(2):140–152

43.

Hall K, Farr B (2004) Diagnosis and management of long-term central venous catheter infections. J Vasc Interv Radiol 15:327–334PubMedCrossRef

44.

Beathard GB (2001) Catheter thrombosis. Semin Dial 14:441–445PubMedCrossRef

45.

Hoshal VL Jr, Ause RG, Hoskins PA (1971) Fibrin sleeve formation on indwelling subclavian central venous catheters. Arch Surg 102:253–258CrossRef

46.

Balestreri L, De Cicco M, Matovic M et al (1995) Central venous catheter-related thrombosis in clinically asymptomatic oncologic patients: a phlebographic study. Eur J Radiol 20:108–111PubMedCrossRef

47.

De Cicco M, Matovic M, Balestreri L et al (1997) Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term Silastic catheter. A prospective study. Thromb Res 86:101–113PubMedCrossRef

48.

Daeihagh P, Jordan J, Chen J et al (2000) Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis 36:75–79PubMedCrossRef

49.

Deitcher SR, Fesen MR, Kiproff PM et al (2002) Cardiovascular thrombolytic to open occluded lines—2 investigators. Safety and efficacy of alteplase for restoring function in occluded central venous catheters: Results of the cardiovascular thrombolytic to open occluded lines trial. J Clin Oncol 20(1):317–324PubMedCrossRef

50.

Angle JF, Shilling AT, Schenk WG et al (2003) Utility of percutaneous intervention in the management of tunneled hemodialysis catheters. Cardiovasc Intervent Radiol 26:9–18PubMedCrossRef

51.

Gray RJ, Levitin A, Buck D et al (2000) Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well-positioned tunneled central venous dialysis catheters: a prospective, randomized trial. J Vasc Intervent Radiol 11:1121–1129CrossRef

52.

Chew H, Wun T, Harvey DJ et al (2007) Incidence of venous thromboembolism and the impact on survival on breast cancer patients. J Clin Oncol 25(1):70–76PubMedCrossRef

53.

Karthaus M, Kretzschmar A, Kroning H et al (2005) Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 176:289–296CrossRef

54.

Couban S, Goodyear M, Burnell M et al (2005) Randomized, placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 23:4063–4069PubMedCrossRef

55.

Kuo YS, Schwartz B, Santiago J, Anderson PS, Fields AL, Goldberg GL (2005) How often should a Port-a-Cath be flushed? Cancer Invest 25:582–585CrossRef

56.

Vescia S, Baumgartner AK, Jacobs VR et al (2008) Management of venous port systems in oncology: a review of current evidence. Ann Oncol 19:9–15PubMedCrossRef

57.

Bern M, Lokich J, Sabina R et al (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 112:423–428PubMed

58.

Owens CA, Bui JT, Knuttinen MG et al (2010) Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. J Vasc Interv Radiol 21:779–787PubMedCrossRef

59.

Kaufman JA, Crenshaw WB, Kuter I et al (1995) Percutaneous placement of a central venous access device via an intercostal vein. Am J Roentgenol 164(2):459–460

60.

Ferral H, Bjarnason H, Wholey M et al (1996) Recanalization of occluded veins to provide access for central catheter placement. J Vasc Interv Radiol 7(5):681–685PubMedCrossRef

Title: Venous Access Ports: Indications, Implantation Technique, Follow-Up, and Complications
Author: Eric M. Walser
Publication date: 01-08-2012
Publisher: Springer-Verlag
Published in: CardioVascular and Interventional Radiology / Issue 4/2012
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-011-0271-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Venous Access Ports: Indications, Implantation Technique, Follow-Up, and Complications

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2012

Complications of Microwave Ablation for Liver Tumors: Results of a Multicenter Study

Palliative Treatment of Rectal Carcinoma Recurrence Using Radiofrequency Ablation

Embolization Therapy for Traumatic Splenic Lacerations

Chemoembolization for Hepatocellular Carcinoma Supplied Exclusively by the Hepatic Falciform Artery

The “SAFARI” Technique Using Retrograde Access Via Peroneal Artery Access

Single-Session Radiofrequency Ablation of Bilateral Lung Metastases